Idiopathic Infantile Hypercalcemia in Children with Chronic Kidney Disease Due to Kidney Hypodysplasia

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2022 Sep 26

PMID 36156733

Authors

Evgenia Gurevich

Yael Borovitz

Shelli Levi

Sharon Perlman

Daniel Landau

Affiliations

Soon will be listed here.

Abstract

Background: Idiopathic infantile hypercalcemia (IIH) etiologies include pathogenic variants in CYP24A1, leading to increased 1,25(OH) D, hypercalciuria and suppressed parathyroid hormone (PTH), and in SLC34A1 and SLC34A3, leading to the same metabolic profile via increased phosphaturia. IIH has not been previously described in CKD due to kidney hypodysplasia (KHD).

Methods: Retrospective study of children with bilateral KHD and simultaneously tested PTH and 1,25(OH)D, followed in a tertiary care center between 2015 and 2021.

Results: Of 295 screened patients, 139 had KHD, of them 16 (11.5%) had IIH (study group), 26 with normal PTH and any 1,25(OH)D were controls. There were no differences between groups' gender, obstructive uropathy rate and baseline eGFR. Study patients were younger [median (IQR) age: 5.2 (3.2-11.3) vs. 61 (13.9-158.3) months, p < 0.001], had higher 1,25(OH)D (259.1 ± 91.7 vs. 156.5 ± 46.4 pmol/l, p < 0.001), total calcium (11.1 ± 0.4 vs. 10.7 ± 0.3 mg/dl, p < 0.001), and lower phosphate standard deviation score (P-SDS) [median (IQR): - 1.4 (- 1.9, - 0.4) vs. - 0.3 (- 0.8, - 0.1), p = 0.03]. During 12 months of follow-up, PTH increased among the study group (8.8 ± 2.8 to 22.7 ± 12.4 pg/ml, p < 0.001), calcium decreased (11 ± 0.5 to 10.3 ± 0.6 mg/dl, p = 0.004), 1,25(OH)D decreased (259.5 ± 91.7 to 188.2 ± 42.6 pmol/l, p = 0.1), P-SDS increased [median (IQR): - 1.4 (- 1.9, - 0.4) vs. - 0.3 (- 0.9, 0.4), p = 0.04], while eGFR increased. Five of 9 study group patients with available urine calcium had hypercalciuria. Five patients had nephrocalcinosis/lithiasis. Genetic analysis for pathogenic variants in CYP24A1, SLC34A1 and SLC34A3 had not been performed.

Conclusions: Transient IIH was observed in infants with KHD, in association with hypophosphatemia, resembling SLC34A1 and SLC34A3 pathogenic variants' metabolic profile. A higher resolution version of the Graphical abstract is available as Supplementary information.

References

Woolf A, Price K, Scambler P, Winyard P . Evolving concepts in human renal dysplasia. J Am Soc Nephrol. 2004; 15(4):998-1007. DOI: 10.1097/01.asn.0000113778.06598.6f. View

Ichikawa I, Kuwayama F, Pope 4th J, Stephens F, Miyazaki Y . Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int. 2002; 61(3):889-98. DOI: 10.1046/j.1523-1755.2002.00188.x. View

Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L . Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2006; 71(1):31-8. DOI: 10.1038/sj.ki.5002009. View

Salusky I, Goodman W, Sahney S, Gales B, Perilloux A, Wang H . Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol. 2005; 16(8):2501-8. DOI: 10.1681/ASN.2004100885. View

Schlingmann K, Kaufmann M, Weber S, Irwin A, Goos C, John U . Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011; 365(5):410-21. DOI: 10.1056/NEJMoa1103864. View

Schlingmann K, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B . Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. J Am Soc Nephrol. 2015; 27(2):604-14. PMC: 4731111. DOI: 10.1681/ASN.2014101025. View

Nesterova G, Malicdan M, Yasuda K, Sakaki T, Vilboux T, Ciccone C . 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis. Clin J Am Soc Nephrol. 2013; 8(4):649-57. PMC: 3613951. DOI: 10.2215/CJN.05360512. View

De Paolis E, Scaglione G, De Bonis M, Minucci A, Capoluongo E . CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med. 2019; 57(11):1650-1667. DOI: 10.1515/cclm-2018-1208. View

Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman E . Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol. 2013; 190(2):552-7. DOI: 10.1016/j.juro.2013.02.3188. View

10.

Meusburger E, Mundlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K . Erratum: Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation. Clin Kidney J. 2016; 6(4):453. PMC: 4898348. DOI: 10.1093/ckj/sft091. View

11.

Al Kalbani N, Frieling M, Teh J, Harvey E, Geary D . Idiopathic hypercalcemia in infants with renal dysplasia. Clin Nephrol. 2011; 75(5):466-71. DOI: 10.5414/cnp75466. View

12.

Feinstein S, Becker-Cohen R, Rinat C, Frishberg Y . Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function. Pediatr Nephrol. 2006; 21(10):1406-12. DOI: 10.1007/s00467-006-0195-2. View

13.

Schwartz G, Munoz A, Schneider M, Mak R, Kaskel F, Warady B . New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20(3):629-37. PMC: 2653687. DOI: 10.1681/ASN.2008030287. View

14.

Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T . Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999; 55(3):1019-27. DOI: 10.1046/j.1523-1755.1999.0550031019.x. View

15.

Petkovich M, Jones G . CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens. 2011; 20(4):337-44. DOI: 10.1097/MNH.0b013e3283477a7b. View

16.

LIGHTWOOD R, Stapleton T . Idiopathic hypercalcaemia in infants. Lancet. 1953; 265(6779):255-6. DOI: 10.1016/s0140-6736(53)90187-1. View

17.

RHANEY K, MITCHELL R . Idiopathic hypercalcaemia of infants. Lancet. 1956; 270(6931):1028-32. DOI: 10.1016/s0140-6736(56)90798-x. View

18.

Janiec A, Halat-Wolska P, Obrycki L, Ciara E, Wojcik M, Pludowski P . Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations. Nephrol Dial Transplant. 2020; 36(8):1484-1492. PMC: 8311581. DOI: 10.1093/ndt/gfaa178. View

19.

Huang J, Coman D, McTaggart S, Burke J . Long-term follow-up of patients with idiopathic infantile hypercalcaemia. Pediatr Nephrol. 2006; 21(11):1676-80. DOI: 10.1007/s00467-006-0217-0. View

20.

Gurevich E, Levi S, Borovitz Y, Alfandary H, Ganon L, Dinour D . Childhood Hypercalciuric Hypercalcemia With Elevated Vitamin D and Suppressed Parathyroid Hormone: Long-Term Follow Up. Front Pediatr. 2021; 9:752312. PMC: 8631469. DOI: 10.3389/fped.2021.752312. View